Hyde Capital is an alternative investment firm.
Hyde Street Capital is an alternative investment firm focused upon opportunistic credit strategies and manages a diversified portfolio of Real Estate Private Credit investments. They originate private debt secured against transitional properties in prime markets throughout the United States targeting value-add and opportunistic acquisitions, recapitalization and repositioning.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 9, 2020
3D Medicines
|
Series Unknown | $140M | Biopharma | — |